Kymera Therapeutics, Inc. — All Filings
540 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-25-314422 | Dec 10, 2025 | Dec 8, 2025 |
| 144 | — | 0001178937-25-000087 | Dec 10, 2025 | — |
| 144 | — | 0001178937-25-000088 | Dec 10, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-311268 | Dec 8, 2025 | — |
| 8-K | 8-K | 0001193125-25-310670 | Dec 8, 2025 | — |
| 4 | 4 | 0001193125-25-311503 | Dec 8, 2025 | — |
| 144 | — | 0001950047-25-009968 | Dec 8, 2025 | — |
| 144 | — | 0001950047-25-009969 | Dec 8, 2025 | — |
| 144 | — | 0001969223-25-001055 | Dec 8, 2025 | — |
| 4 | 4 | 0001193125-25-311504 | Dec 8, 2025 | — |
| 4 | 4 | 0001193125-25-311505 | Dec 8, 2025 | — |
| 8-K | 8-K | 0001193125-25-310572 | Dec 8, 2025 | — |
| SCHEDULE 13G/A | — | 0000080255-25-000835 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002767 | Nov 5, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-263550 | Nov 4, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-263540 | Nov 4, 2025 | — |
| 144 | — | 0001969223-25-000889 | Oct 29, 2025 | — |
| 4 | 4 | 0001193125-25-256673 | Oct 29, 2025 | — |
| 144 | — | 0001950047-25-008003 | Oct 15, 2025 | — |
| 4 | 4 | 0001193125-25-240430 | Oct 15, 2025 | — |
| 4 | 4 | 0001193125-25-238130 | Oct 14, 2025 | Oct 13, 2025 |
| 4 | 4 | 0001193125-25-239144 | Oct 14, 2025 | Oct 13, 2025 |
| 144 | — | 0001950047-25-007920 | Oct 14, 2025 | — |
| 144 | — | 0001950047-25-007916 | Oct 14, 2025 | — |
| 144 | — | 0001950047-25-007269 | Sep 17, 2025 | — |
| 4 | 4 | 0001193125-25-206350 | Sep 17, 2025 | — |
| 4 | 4 | 0001193125-25-204997 | Sep 16, 2025 | — |
| 144 | — | 0001969223-25-000775 | Sep 16, 2025 | — |
| 4 | 4 | 0001193125-25-195044 | Sep 3, 2025 | — |
| 3 | 3 | 0001193125-25-195035 | Sep 3, 2025 | — |
| 8-K | 8-K | 0001193125-25-194481 | Sep 3, 2025 | Aug 27, 2025 |
| SCHEDULE 13G/A | — | 0000902219-25-000333 | Aug 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-106227 | Aug 11, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-106229 | Aug 11, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0002052113-25-003210 | Jul 17, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0000921895-25-001910 | Jul 1, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-091829 | Jun 30, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-064298 | Jun 30, 2025 | — |
| 8-K | 8-K | 0001193125-25-151345 | Jun 27, 2025 | Jun 25, 2025 |
| 8-K | 8-K | 0001193125-25-151393 | Jun 27, 2025 | Jun 25, 2025 |
| 424B5 | 424B5 | 0001193125-25-151288 | Jun 27, 2025 | — |
| 4 | 4 | 0000950170-25-090580 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090579 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090581 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090586 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090582 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090583 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090584 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090585 | Jun 26, 2025 | Jun 25, 2025 |
| 8-K | 8-K | 0001193125-25-146135 | Jun 25, 2025 | — |